Northeast Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $369K | Hold |
6,407
| – | – | 0.01% | 164 |
|
|
2026
Q1 | $389K | Buy |
6,407
+232
| +4% | +$13.5K | 0.02% | 152 |
|
|
2025
Q4 | $333K | Sell |
6,175
-530
| -8% | -$25.5K | 0.01% | 157 |
|
|
2025
Q3 | $302K | Sell |
6,705
-1,255
| -16% | -$58.6K | 0.01% | 154 |
|
|
2025
Q2 | $368K | Hold |
7,960
| – | – | 0.02% | 146 |
|
|
2025
Q1 | $485K | Sell |
7,960
-679
| -8% | -$39.6K | 0.02% | 131 |
|
|
2024
Q4 | $489K | Sell |
8,639
-300
| -3% | -$16.8K | 0.02% | 133 |
|
|
2024
Q3 | $463K | Sell |
8,939
-207
| -2% | -$9.71K | 0.02% | 139 |
|
|
2024
Q2 | $380K | Sell |
9,146
-795
| -8% | -$35.6K | 0.02% | 147 |
|
|
2024
Q1 | $539K | Sell |
9,941
-1,600
| -14% | -$81.5K | 0.03% | 134 |
|
|
2023
Q4 | $592K | Sell |
11,541
-720
| -6% | -$37.8K | 0.03% | 124 |
|
|
2023
Q3 | $712K | Buy |
12,261
+1,800
| +17% | +$110K | 0.04% | 117 |
|
|
2023
Q2 | $669K | Sell |
10,461
-35
| -0.3% | -$2.35K | 0.04% | 117 |
|
|
2023
Q1 | $727K | Sell |
10,496
-35
| -0.3% | -$2.47K | 0.04% | 111 |
|
|
2022
Q4 | $758K | Sell |
10,531
-1,709
| -14% | -$129K | 0.05% | 110 |
|
|
2022
Q3 | $870K | Sell |
12,240
-50
| -0.4% | -$3.63K | 0.06% | 98 |
|
|
2022
Q2 | $946K | Sell |
12,290
-1,056
| -8% | -$80.4K | 0.06% | 102 |
|
|
2022
Q1 | $975K | Sell |
13,346
-231
| -2% | -$15.5K | 0.05% | 113 |
|
|
2021
Q4 | $847K | Buy |
13,577
+146
| +1% | +$8.56K | 0.04% | 116 |
|
|
2021
Q3 | $795K | Buy |
13,431
+680
| +5% | +$44.8K | 0.04% | 118 |
|
|
2021
Q2 | $852K | Sell |
12,751
-907
| -7% | -$59.1K | 0.05% | 114 |
|
|
2021
Q1 | $862K | Sell |
13,658
-109
| -0.8% | -$6.78K | 0.05% | 112 |
|
|
2020
Q4 | $854K | Sell |
13,767
-573
| -4% | -$35.2K | 0.05% | 108 |
|
|
2020
Q3 | $865K | Sell |
14,340
-81
| -0.6% | -$4.88K | 0.06% | 103 |
|
|
2020
Q2 | $848K | Buy |
14,421
+820
| +6% | +$49K | 0.06% | 95 |
|
|
2020
Q1 | $758K | Sell |
13,601
-531
| -4% | -$32.5K | 0.07% | 91 |
|
|
2019
Q4 | $907K | Sell |
14,132
-179
| -1% | -$10.3K | 0.07% | 102 |
|
|
2019
Q3 | $726K | Sell |
14,311
-10,955
| -43% | -$515K | 0.06% | 108 |
|
|
2019
Q2 | $1.15M | Sell |
25,266
-66,517
| -72% | -$3.1M | 0.09% | 97 |
|
|
2019
Q1 | $4.38M | Sell |
91,783
-64,345
| -41% | -$3.21M | 0.37% | 63 |
|
|
2018
Q4 | $8.12M | Sell |
156,128
-134,208
| -46% | -$7.21M | 0.78% | 41 |
|
|
2018
Q3 | $18M | Sell |
290,336
-3,487
| -1% | -$207K | 1.44% | 27 |
|
|
2018
Q2 | $16.3M | Sell |
293,823
-17,117
| -6% | -$924K | 1.38% | 27 |
|
|
2018
Q1 | $19.7M | Buy |
310,940
+8,252
| +3% | +$531K | 1.74% | 18 |
|
|
2017
Q4 | $18.5M | Buy |
302,688
+29,772
| +11% | +$1.86M | 1.56% | 24 |
|
|
2017
Q3 | $17.4M | Buy |
272,916
+5,960
| +2% | +$348K | 1.54% | 25 |
|
|
2017
Q2 | $14.9M | Sell |
266,956
-2,755
| -1% | -$150K | 1.35% | 29 |
|
|
2017
Q1 | $14.7M | Sell |
269,711
-2,821
| -1% | -$155K | 1.37% | 29 |
|
|
2016
Q4 | $15.9M | Sell |
272,532
-14,036
| -5% | -$767K | 1.53% | 24 |
|
|
2016
Q3 | $15.5M | Buy |
286,568
+6,803
| +2% | +$437K | 1.54% | 23 |
|
|
2016
Q2 | $20.6M | Buy |
279,765
+28,494
| +11% | +$2.01M | 2.07% | 16 |
|
|
2016
Q1 | $16.1M | Buy |
251,271
+23,071
| +10% | +$1.45M | 1.65% | 23 |
|
|
2015
Q4 | $15.7M | Buy |
228,200
+28,447
| +14% | +$1.88M | 1.63% | 24 |
|
|
2015
Q3 | $11.8M | Buy |
199,753
+21,472
| +12% | +$1.36M | 1.28% | 30 |
|
|
2015
Q2 | $11.9M | Buy |
178,281
+28,301
| +19% | +$1.87M | 1.2% | 33 |
|
|
2015
Q1 | $9.67M | Buy |
149,980
+30,288
| +25% | +$1.9M | 0.95% | 42 |
|
|
2014
Q4 | $7.07M | Buy |
119,692
+28,387
| +31% | +$1.6M | 0.69% | 50 |
|
|
2014
Q3 | $4.67M | Buy |
91,305
+48,807
| +115% | +$2.44M | 0.47% | 60 |
|
|
2014
Q2 | $2.06M | Buy |
+42,498
| New | +$2.09M | 0.21% | 84 |
|
|
2013
Q4 | – | Sell |
-5,166
| Closed | -$239K | – | 163 |
|
|
2013
Q3 | $239K | Buy |
+5,166
| New | +$227K | 0.03% | 147 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
Northeast Investment Management's BMY Position: Q2 2026 in Review
Northeast Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,407 shares worth $369K. The position accounts for 0.01% of the portfolio, ranked #164.
Northeast Investment Management first reported a position in BMY in Q3 2013 and has held it in 50 quarters since. The position peaked at $20.6M in Q2 2016. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Northeast Investment Management held 6,407 shares of Bristol-Myers Squibb worth $369K as of Q2 2026.
- Northeast Investment Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.01% of Northeast Investment Management's portfolio in Q2 2026, its #164 holding.
- Northeast Investment Management first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 50 quarters since.
- Northeast Investment Management's Bristol-Myers Squibb position peaked at $20.6M in Q2 2016.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.